Latest Breaking News On - Incyte corporation nasdaq - Page 1 : comparemela.com

Incyte Corporation announces an Equity Buyback for $1,672 million worth of its shares.

Incyte Corporation announces an Equity Buyback for $1,672 million worth of its shares.
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Incyte-corporation-nasdaq
Incyte-corporation

Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock

Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
New-york
Netherlands
Dutch
America
Julianc-baker
Baker-entitie
Felixj-baker
Goldman-sachs-co
Nasdaq
Exchange-commission-sec-incyte
Exchange-commission

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

/PRNewswire/ Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China s leading provider of cord blood collection, laboratory testing,.

China
New-york
United-states
Xu-ping
Gansu
City-of-new-york
Cayman-islands
British-virgin-islands
William-zima
Cellenkos-inc
Incyte-corporation-nasdaq
Federal-reserve-bank

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

/PRNewswire/ Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China s leading provider of cord blood collection, laboratory testing,.

China
New-york
United-states
Xu-ping
Gansu
City-of-new-york
Cayman-islands
British-virgin-islands
William-zima
Cellenkos-inc
Incyte-corporation-nasdaq
Federal-reserve-bank

Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

HONG KONG, April 30, 2022 /PRNewswire/ Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

China
Texas
United-states
Cellenko-tregs
Simrit-parmar
Incyte-corporation-nasdaq
Cellenkos-inc
Strategic-development-agreement
Global-cord-blood-corporation
Board-of-directors-the-company
Incyte-corporation
Anderson-cancer-centre